Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of EyePoint (NASDAQ:EYPT) through any online brokerage.
Other companies in EyePoint’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
EyePoint has a consensus price target of $27.08.
The stock price for EyePoint (NASDAQ: EYPT) is $3.17 last updated October 6, 2026 at 4:41 PM EDT.
There are no upcoming dividends for EyePoint.
EyePoint does not have any upcoming earnings scheduled.
There is no upcoming split for EyePoint.
EyePoint is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
EyePoint Inc focuses is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, that may reduce the frequency of follow-up care. The company's...